Pathophysiology of Human Visceral Obesity: An Update
2013· review· en· Physiological Reviews· Medicine
aff
2,712
citations
Works
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Route
Field
Type
Language
Year range
to
Screen consensus
Sort
Flags
Screening evidence
Direct labels are sparse and unvalidated. Missing labels are unknown.
1 filter active
2,032 workspage 1 of 82
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023· review· en· Journal of Hepatology· Medicine
afffund
2,698
citations
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
2022· review· en· The Lancet. Gastroenterology & hepatology· Medicine
afffundno abstract
2,117
citations
1,996
citations
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017· review· en· Hepatology· Medicine
afffund
1,898
citations
Nonalcoholic fatty liver disease
2005· review· en· Canadian Medical Association Journal· Medicine
venueno aff
1,619
citations
1,501
citations
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
2016· article· en· Journal of Hepatology· Medicine
affno abstract
1,246
citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019· article· en· The Lancet· Medicine
affno abstract
1,213
citations
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
2020· review· en· Gastroenterology· Medicine
afffundno abstract
1,018
citations
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children
2016· article· en· Journal of Pediatric Gastroenterology and Nutrition· Medicine
aff
1,001
citations
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
2013· article· en· Nature Medicine· Biochemistry, Genetics and Molecular Biology
afffund
875
citations
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023· review· en· Annals of Hepatology· Medicine
aff
794
citations
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis
2006· article· en· Cell Metabolism· Medicine
affno abstract
751
citations
Intestinal microbiota in patients with nonalcoholic fatty liver disease
2013· article· en· Hepatology· Biochemistry, Genetics and Molecular Biology
afffund
737
citations
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
2004· article· en· Hepatology· Medicine
aff
729
citations
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways
2001· article· en· Journal of Clinical Investigation· Biochemistry, Genetics and Molecular Biology
afffund
705
citations
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
2008· review· en· World Journal of Gastroenterology· Medicine
aff
698
citations
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
2013· article· en· Clinical Gastroenterology and Hepatology· Engineering
afffundno abstract
668
citations
AMPK as a Therapeutic Target for Treating Metabolic Diseases
2017· review· en· Trends in Endocrinology and Metabolism· Biochemistry, Genetics and Molecular Biology
affno abstract
628
citations
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
2019· review· en· Endocrine Reviews· Medicine
fundno aff
599
citations
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
2017· article· en· Hepatology· Medicine
aff
553
citations
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
2015· article· en· Gut· Biochemistry, Genetics and Molecular Biology
aff
551
citations
Targeting metabolic dysregulation for fibrosis therapy
2019· review· en· Nature Reviews Drug Discovery· Medicine
affno abstract
528
citations
Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis
2013· article· en· Radiology· Medicine
afffund
526
citations